Aktie A2PJ4V SIO GENE THERAPIES INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Sio Gene Therapies Inc.

Aktien

A2PJ4V

US8293991043

SIOX

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Sio Gene Therapies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Sio Gene Therapies : Announces Fiscal First Quarter 2022 Financial Results - Form 8-K
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PJ4V Aktie
  4. Nachrichten Sio Gene Therapies Inc.
  5. Andere Sprachen